[1] |
HEYLEN L, PIRENNE J, NAESENS M, et al. "Time is tissue"-a minireview on the importance of donor nephrectomy, donor hepatectomy, and implantation times in kidney and liver transplantation[J]. Am J Transplant, 2021, DOI: 10.1111/ajt.16580[Epub ahead of print].
|
[2] |
谷带利, 谢智钦, 唐才喜. 人抗原R: 小鼠和人类肝移植损伤中一种新的血红素氧合酶-1细胞保护调节剂[J]. 临床肝胆病杂志, 2020, 36(4): 931. doi: 10.3969/j.issn.1001-5256.2020.04.060GU DL, XIE ZX, TANG CX. Human antigen R(HuR): a new regulator of heme oxygenase-2 cytoprotection in mouse and human liver transplant injury[J]. J Clin Hepatol, 2020, 36(4): 931. doi: 10.3969/j.issn.1001-5256.2020.04.060
|
[3] |
LIN MJ, LI S, YANG LJ, et al. Plasma membrane vesicles of human umbilical cord mesenchymal stem cells ameliorate acetaminophen-induced damage in HepG2 cells: a novel stem cell therapy[J]. Stem Cell Res Ther, 2020, 11(1): 225. DOI: 10.1186/s13287-020-01738-z.
|
[4] |
HU C, WU Z, LI L. Mesenchymal stromal cells promote liver regeneration through regulation of immune cells[J]. Int J Biol Sci, 2020, 16(5): 893-903. DOI: 10.7150/ijbs.39725.
|
[5] |
YOU Y, WEN DG, GONG JP, et al. Research status of mesenchymal stem cells in liver transplantation[J]. Cell Transplant, 2019, 28(12): 1490-1506. DOI: 10.1177/0963689719874786.
|
[6] |
HU C, LI L. The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation[J]. J Transl Med, 2019, 17(1): 412. DOI: 10.1186/s12967-019-02167-0.
|
[7] |
SOUNDARA RAJAN T, GUGLIANDOLO A, BRAMANTI P, et al. Tunneling nanotubes-mediated protection of mesenchymal stem cells: an update from preclinical studies[J]. Int J Mol Sci, 2020, 21(10): 3481. DOI: 10.3390/ijms21103481.
|
[8] |
FENG Y, ZHU R, SHEN J, et al. Human bone marrow mesenchymal stem cells rescue endothelial cells experiencing chemotherapy stress by mitochondrial transfer via tunneling nanotubes[J]. Stem Cells Dev, 2019, 28(10): 674-682. DOI: 10.1089/scd.2018.0248.
|
[9] |
HAN D, ZHENG X, WANG X, et al. Mesenchymal stem/stromal cell-mediated mitochondrial transfer and the therapeutic potential in treatment of neurological diseases[J]. Stem Cells Int, 2020: 8838046. DOI: 10.1155/2020/8838046.
|
[10] |
MOHAMMADALIPOUR A, DUMBALI SP, WENZEL PL. Mitochondrial transfer and regulators of mesenchymal stromal cell function and therapeutic efficacy[J]. Front Cell Dev Biol, 2020, 8: 603292. DOI: 10.3389/fcell.2020.603292.
|
[11] |
RUSSO L, GRACIA-SANCHO J, GARCÍA-CALDERÓ H, et al. Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers[J]. Hepatology, 2012, 55(3): 921-930. DOI: 10.1002/hep.24755.
|
[12] |
SELZNER N, LIU H, BOEHNERT MU, et al. FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice[J]. J Hepatol, 2012, 56(1): 153-159. DOI: 10.1016/j.jhep.2011.05.033.
|
[13] |
ZHANG Z, JIN X, YANG C, et al. Teneligliptin protects against hypoxia/reoxygenation-induced endothelial cell injury[J]. Biomed Pharmacother, 2019, 109: 468-474. DOI: 10.1016/j.biopha.2018.10.016.
|
[14] |
HUANG H, TOHME S, AL-KHAFAJI AB, et al. Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury[J]. Hepatology, 2015, 62(2): 600-614. DOI: 10.1002/hep.27841.
|
[15] |
BAKIRI L, HAMACHER R, GRAÑA O, et al. Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation[J]. J Exp Med, 2017, 214(5): 1387-1409. DOI: 10.1084/jem.20160935.
|
[16] |
YAO J, ZHENG J, CAI J, et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response[J]. FASEB J, 2019, 33(2): 1695-1710. DOI: 10.1096/fj.201800131RR.
|
[17] |
SUN Y, WANG Y, ZHOU L, et al. Spheroid-cultured human umbilical cord-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury in rats[J]. Sci Rep, 2018, 8(1): 2518. DOI: 10.1038/s41598-018-20975-0.
|
[18] |
POURMOHAMMADI-BEJARPASI Z, ROUSHANDEH AM, SABERI A, et al. Mesenchymal stem cells-derived mitochondria transplantation mitigates I/R-induced injury, abolishes I/R-induced apoptosis, and restores motor function in acute ischemia stroke rat model[J]. Brain Res Bull, 2020, 165: 70-80. DOI: 10.1016/j.brainresbull.2020.09.018.
|
[19] |
BI ZM, ZHOU QF, GENG Y, et al. Human umbilical cord mesenchymal stem cells ameliorate experimental cirrhosis through activation of keratinocyte growth factor by suppressing microRNA-199[J]. Eur Rev Med Pharmacol Sci, 2016, 20(23): 4905-4912.
|
[20] |
AMIN MA, SABRY D, RASHED LA, et al. Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study[J]. Clin Transplant, 2013, 27(4): 607-612. DOI: 10.1111/ctr.12179.
|
[21] |
GHAVAMZADEH A, SOTOUDEH M, HASHEMI TAHERI AP, et al. Liver fibrosis alleviation after co-transplantation of hematopoietic stem cells with mesenchymal stem cells in patients with thalassemia major[J]. Ann Hematol, 2018, 97(2): 327-334. DOI: 10.1007/s00277-017-3181-9.
|
[22] |
SHIN B, COWAN DB, EMANI SM, et al. Mitochondrial transplantation in myocardial ischemia and reperfusion injury[J]. Adv Exp Med Biol, 2017, 982: 595-619. DOI: 10.1007/978-3-319-55330-6_31.
|
[23] |
GO KL, LEE S, ZENDEJAS I, et al. Mitochondrial dysfunction and autophagy in hepatic ischemia/reperfusion injury[J]. Biomed Res Int, 2015: 183469. DOI: 10.1155/2015/183469.
|
[24] |
MUI D, ZHANG Y. Mitochondrial scenario: roles of mitochondrial dynamics in acute myocardial ischemia/reperfusion injury[J]. J Recept Signal Transduct Res, 2021, 41(1): 1-5. DOI: 10.1080/10799893.2020.1784938.
|
[25] |
GU J, ZHANG T, GUO J, et al. PINK1 Activation and translocation to mitochondria-associated membranes mediates mitophagy and protects against hepatic ischemia/reperfusion injury[J]. Shock, 2020, 54(6): 783-793. DOI: 10.1097/SHK.0000000000001534.
|
[26] |
DENG F, WANG S, ZHANG L, et al. Propofol through upregulating caveolin-3 attenuates post-hypoxic mitochondrial damage and cell death in H9C2 cardiomyocytes during hyperglycemia[J]. Cell Physiol Biochem, 2017, 44(1): 279-292. DOI: 10.1159/000484680.
|
[27] |
PARADIES G, PARADIES V, RUGGIERO FM, et al. Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection[J]. Am J Physiol Heart Circ Physiol, 2018, 315(5): H1341-H1352. DOI: 10.1152/ajpheart.00028.2018.
|
[28] |
LESNEFSKY EJ, CHEN Q, TANDLER B, et al. Mitochondrial dysfunction and myocardial ischemia-reperfusion: implications for novel therapies[J]. Annu Rev Pharmacol Toxicol, 2017, 57: 535-565. DOI: 10.1146/annurev-pharmtox-010715-103335.
|
[29] |
JOHNSON K, MCEVOY CE, NAQVI S, et al. High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11: 799-807. DOI: 10.2147/COPD.S102375.
|
[30] |
LI X, MICHAELOUDES C, ZHANG Y, et al. Mesenchymal stem cells alleviate oxidative stress-induced mitochondrial dysfunction in the airways[J]. J Allergy Clin Immunol, 2018, 141(5): 1634-1645. DOI: 10.1016/j.jaci.2017.08.017.
|